Pardes Biosciences Inc.

NASDAQ: PRDS · Real-Time Price · USD
2.18
0.02 (0.93%)
At close: Aug 30, 2023, 9:59 PM

Pardes Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
100.27M 47.16M 59.28M 209.06M 228.6M 247.92M 268.68M 26.38M 353.35K 8.8K
Short-Term Investments
52.93M 125.07M 138.06M n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a 201.26M n/a
Other Long-Term Assets
n/a n/a 219K n/a n/a n/a n/a 1.52M n/a 82.9K
Receivables
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
4.11M 3.91M 3.06M 4.99M 5.25M 7.22M 6.58M 676K 636.43K n/a
Total Current Assets
157.31M 176.15M 200.4M 214.04M 233.85M 255.14M 275.26M 27.06M 989.77K 8.8K
Property-Plant & Equipment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
n/a n/a 219K n/a n/a n/a n/a 1.52M 201.26M 82.9K
Total Assets
157.31M 176.15M 200.62M 214.04M 233.85M 255.14M 275.26M 28.58M 202.25M 91.7K
Account Payables
14K 3.71M 4.93M 1.57M 1.68M 2.37M 2.38M 2.75M 142.07K 1.03K
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
1.91M 7.7M 15.5M 10.46M 9.54M 6.4M 6.58M 3.22M 1.55M 66.7K
Total Current Liabilities
1.93M 11.41M 20.43M 12.03M 11.22M 8.76M 8.96M 5.97M 1.69M 67.73K
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a 59.13M 7.04M n/a
Total Long-Term Liabilities
n/a 3.71M 4.93M 1.57M 1.68M n/a n/a 59.13M 7.04M n/a
Total Liabilities
1.93M 11.41M 20.43M 12.03M 11.22M 8.76M 8.96M 65.1M 8.74M 67.73K
Total Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock
6K 6K 6K 6K 6K 6K 6K n/a 188.51M 503.00
Retained Earnings
-176.74M -165.96M -148.16M -123.94M -100.6M -72.96M -51.52M -37.18M -2.34M -1.03K
Comprehensive Income
9K -23K -24K n/a n/a n/a n/a n/a n/a n/a
Shareholders Equity
155.38M 164.73M 180.2M 202.01M 222.63M 246.38M 266.29M -36.52M 5M 23.97K
Total Investments
52.93M 125.07M 138.06M n/a n/a n/a n/a n/a 201.26M n/a